Researchers aim to create, validate risk calculator and screening tool to identify and test high-risk individuals
Conference to be held in Las Vegas brings together experts with patients and caregivers
Assessment reveals desperately slow period in drug development, with only eight new agents entering Phase I since 2016
$6 million grant to support research for common but little-known brain disease
Study adds to the questions surrounding the safety of calcium supplements
